{"id":495,"date":"2015-04-06T16:55:23","date_gmt":"2015-04-06T20:55:23","guid":{"rendered":"http:\/\/www.ipoboutique.com\/blog\/?p=495"},"modified":"2015-04-06T16:55:23","modified_gmt":"2015-04-06T20:55:23","slug":"secondaries-announced-4-6-2015","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/secondaries-announced-4-6-2015\/","title":{"rendered":"Secondaries announced 4.6.2015"},"content":{"rendered":"<p>IPOBoutique.Com rates secondary offerings to hit the tape with a \u2018BUY\u2019, \u2018NEUTRAL\u2019 or \u2018AVOID\u2019 rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary\u2019s he\u2019s issued with a \u2018BUY\u2019 rating.<\/p>\n<p>Company: Cerulean Pharma Inc.<br \/>\nSymbol: CERU<br \/>\nPrice: Last trade $7.25<br \/>\nTrade Date: 4\/7<br \/>\nShares: 4.8 million<br \/>\nUnderwriter(s) Leerink Partner, Barclays Capital<br \/>\nCo Manager(s) Canaccord Genuity, JMP Securities, Wedbush PacGrow<br \/>\n<a href=\" https:\/\/www.ipoboutique.com\/Subscribe.html\">Rating=Subscription Needed<\/a><\/p>\n<p>Company: Realty Income<br \/>\nSymbol: O<br \/>\nPrice: Last trade $52.05<br \/>\nTrade Date: 4\/7<br \/>\nShares: 5 million<br \/>\nUnderwriter(s) RBC Capital Markets, BofA Merrill Lynch, J.P. Morgan, Morgan Stanley<br \/>\n<a href=\" https:\/\/www.ipoboutique.com\/Subscribe.html\">Rating=Subscription Needed<\/a><\/p>\n<p>Company: Telefonica Brasil, S.A.<br \/>\nSymbol: VIV<br \/>\nPrice: Last trade $15.54<br \/>\nTrade Date: 4\/16<br \/>\nShares: 220 million<br \/>\nUnderwriter(s) Itau BBA, Morgan Stanley, BofA merrill Lynch, Santander, Bradesco BBI, BTG Pactual, Credit Suisse, Goldman Sachs, HSBC, J.P. Morgan<br \/>\n<a href=\" https:\/\/www.ipoboutique.com\/Subscribe.html\">Rating=Subscription Needed<\/a><\/p>\n<p>Company: Prothena Corporation plc<br \/>\nSymbol: PRTA<br \/>\nPrice: Last trade $38.82<br \/>\nTrade Date: 4\/8<br \/>\nShares: 3.3 million<br \/>\nUnderwriter(s) Credit Suisse, RBC Capital Markets<br \/>\n<a href=\" https:\/\/www.ipoboutique.com\/Subscribe.html\">Rating=Subscription Needed<\/a><\/p>\n<p>Company: Dyax<br \/>\nSymbol: DYAX<br \/>\nPrice: Last trade $28.61<br \/>\nTrade Date: 4\/8<br \/>\nShares: 7 million<br \/>\nUnderwriter(s) BofA Merrill Lynch, Cowen &amp; Co., RBC Capital Markets<br \/>\nCo Manager(s) Needham &amp; Co., Wedbush PacGrow<br \/>\n<a href=\" https:\/\/www.ipoboutique.com\/Subscribe.html\">Rating=Subscription Needed<\/a><\/p>\n<p>Company: Genesis Energy LP<br \/>\nSymbol: GEL<br \/>\nPrice: Last trade $46.95<br \/>\nTrade Date: 4\/7<br \/>\nShares: 4.0 million<br \/>\nUnderwriter(s) Wells Fargo Securities,BofA Merrill Lynch, Citigroup, Deutsche Bank Securities, RBC Capital Markets, Credit Suisse, Raymond James, UBS Investment Bank<br \/>\nCo Manager(s) Baird, BMO Capital Markets, Janney Montgomery Scott<br \/>\n<a href=\" https:\/\/www.ipoboutique.com\/Subscribe.html\">Rating=Subscription Needed<\/a><\/p>\n<p>Company: Felcor Lodging<br \/>\nSymbol: FCH<br \/>\nPrice: Last trade $12.10<br \/>\nTrade Date: 4\/9<br \/>\nShares: 14.5 million<br \/>\nUnderwriter(s) J. P. Morgan, BofA Merrill Lynch<br \/>\n<a href=\" https:\/\/www.ipoboutique.com\/Subscribe.html\">Rating=Subscription Needed<\/a><\/p>\n<p>Company: Hudson Pacific Properties, Inc.<br \/>\nSymbol: HPP<br \/>\nPrice: Last trade $33.95<br \/>\nTrade Date: 4\/7<br \/>\nShares: 5.0 million<br \/>\nUnderwriter(s) BofA Merrill Lynch, Wells Fargo Securities<br \/>\n<a href=\" https:\/\/www.ipoboutique.com\/Subscribe.html\">Rating=Subscription Needed<\/a><\/p>\n<p>Company: Omega Healthcare Investors Inc.-BLOCK<br \/>\nSymbol: OHI<br \/>\nPrice: Last trade $41.94<br \/>\nTrade Date: 4\/7<br \/>\nShares: 18.0 million<br \/>\nUnderwriter(s) Morgan Stanley<br \/>\n<a href=\" https:\/\/www.ipoboutique.com\/Subscribe.html\">Rating=Subscription Needed<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>IPOBoutique.Com rates secondary offerings to hit the tape with a \u2018BUY\u2019, \u2018NEUTRAL\u2019 or \u2018AVOID\u2019 rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary\u2019s he\u2019s issued with a \u2018BUY\u2019 rating. Company: Cerulean Pharma Inc. Symbol: CERU Price: Last trade $7.25 Trade Date: 4\/7 Shares: 4.8 million Underwriter(s) Leerink Partner, Barclays Capital Co[&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[35],"tags":[277,292,294,293,295,289,93,291,290],"class_list":["post-495","post","type-post","status-publish","format-standard","hentry","category-secondary-offerings","tag-ceru","tag-dyax","tag-fch","tag-gel","tag-hpp","tag-o","tag-ohi","tag-prta","tag-viv"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/495","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=495"}],"version-history":[{"count":1,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/495\/revisions"}],"predecessor-version":[{"id":506,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/495\/revisions\/506"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=495"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=495"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=495"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}